Antibe Therapeutics

(ATBPF)

By |

Profile

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin.

Contact Information

Website: www.antibethera.com
Main Phone: +1 416 922-3460
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQB
CEO: Daniel Legault
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin.

Contact Information

Website: www.antibethera.com
Main Phone: +1 416 922-3460
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQB
CEO: Daniel Legault
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.49 $ 0.0196 (4.14%)
Last Price 0.49 Change $ 0.0196 Change % 4.14 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.49 High 0.50 Low 0.47 Prev Close 0.47
Last Trade Volume 215,674 52 Wk Hi 0.52 52 Wk Low 0.20
Market Cap 135.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 286,710,963.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB